Pro Medicus (ASX: PME) has signed a seven-year, A$40 million contract with LucidHealth, a leading US-based radiology provider ...

Pro Medicus (ASX: PME) has signed a seven-year, A$40 million contract with LucidHealth, a leading US-based radiology provider. The deal will see LucidHealth adopt Pro Medicus’ Visage 7 ...

Pro Medicus’ strategy revolves around renewing ... Most of the firm’s expenses are allocated to over 40 software engineers with the main R&D center located in Berlin. The company also recently ...

Currently, Visage 7 is limited to radiology departments, but Pro Medicus is aiming to extend the product set to other ...

for a total committed minimum value of AUD 40 million over seven years. Planning for the rollout is commencing immediately based on Pro Medicus’ established cloud-based implementation and we ...

Bell Potter currently has a buy rating and $330.00 price target on its shares. This suggests that upside of 40% is possible ...

Pro Medicus Ltd (ASX:PME) has signed a seven-year contract worth A$40 million with U.S. radiology service provider LucidHealth which will see the latter implement the cloud-based Visage 7 enterprise ...

The Pro Medicus share price is lifting off after management reported that Visage Imaging, the company's wholly owned US subsidiary, has signed a $40 million seven-year contract with LucidHealth.

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 27 years, gives his ...

Anesthesia providers continue to face significant financial challenges as reimbursement rates decline and workforce shortages loom. Here are 10 numbers that highlight the growing crisis in anesthesia ...